BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 198295)

  • 1. [Efficacy testing of anti-foot-and-mouth disease vaccines in guinea pigs using myotropic strains].
    Eissner G; Böhm HO
    Dev Biol Stand; 1976; 35():279-83. PubMed ID: 198295
    [No Abstract]   [Full Text] [Related]  

  • 2. [Testing of the activity of anti-foot-and-mouth disease vaccines].
    Fédida M; Dannacher G; Coudert M; Perrin M; Martel JL
    Dev Biol Stand; 1976; 35():243-70. PubMed ID: 198292
    [No Abstract]   [Full Text] [Related]  

  • 3. Some problems of testing foot-and-mouth disease vaccines. II. Potency testing.
    Soós T
    Acta Vet Hung; 1987; 35(3):331-42. PubMed ID: 2829602
    [No Abstract]   [Full Text] [Related]  

  • 4. [The efficacy of foot and mouth disease vaccines after long- term storage].
    Wittmann G
    Berl Munch Tierarztl Wochenschr; 1980 Jan; 93(2):33-4. PubMed ID: 6248022
    [No Abstract]   [Full Text] [Related]  

  • 5. [Analysis of the immunologic properties of foot-and-mouth disease vaccines].
    Tekerlekov P; Gergov P; Nikolova E
    Vet Med Nauki; 1982; 19(3):29-34. PubMed ID: 6291225
    [No Abstract]   [Full Text] [Related]  

  • 6. Liposome encapsulated subunit (VP1) and virion vaccines against foot-and-mouth disease.
    Vasantha S; Antony A; Lal SM
    Acta Virol; 1987 Mar; 31(2):109-15. PubMed ID: 2886019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An alternative method for the control of anti-aphthae vaccines].
    Leunen J; Strobbe R
    Bull Mem Acad R Med Belg; 1986; 141(5-6):335-42. PubMed ID: 3026535
    [No Abstract]   [Full Text] [Related]  

  • 8. Derivatives of aziridine as inactivants for foot-and-mouth disease virus vaccines.
    Warrington RE; Cunliffe HR; Bachrach HL
    Am J Vet Res; 1973 Aug; 34(8):1087-91. PubMed ID: 4356910
    [No Abstract]   [Full Text] [Related]  

  • 9. [Post-vaccinal immunity against heterologous subtypes of the foot-and-mouth disease virus].
    Sobko AI; Sokolov LN; Mishchenko VA; Maslova NS; Dudnikov AI
    Veterinariia; 1977 Sep; (9):42-4. PubMed ID: 202059
    [No Abstract]   [Full Text] [Related]  

  • 10. Storage-related potency changes in monovalent type O1, A5 and C foot-and-mouth disease vaccine preparations.
    Sólyom F; Fazekas A; Czelleng F
    Acta Vet Acad Sci Hung; 1981; 28(3):289-95. PubMed ID: 6266237
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative testing of methods for the control of foot-and-mouth disease vaccines on guinea pigs].
    Tekerlekov P; Mitev G; Nikolova E; Gergov P
    Vet Med Nauki; 1975; 12(1):25-9. PubMed ID: 1209994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guinea pig protection test as indicator of potency of oil emulsion foot-and-mouth disease vaccines.
    Black L; Pullen L; Boge A
    Res Vet Sci; 1985 Sep; 39(2):207-11. PubMed ID: 2999930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [On testing the efficiency of foot-and-mouth disease hyperimmune serum in guinea pigs by injecting myotropic foot-and-mouth disease virus strains].
    Bengelsdorff HJ
    Zentralbl Veterinarmed B; 1965 Jul; 12(4):340-50. PubMed ID: 4283976
    [No Abstract]   [Full Text] [Related]  

  • 14. Attempts at potency testing of foot-and-mouth disease vaccines by evaluation of the complement fixing capacity of eluates.
    Bauer K
    Dev Biol Stand; 1976; 35():297-300. PubMed ID: 198299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intranasal vaccination of cattle against foot-and-mouth disease].
    Bauer K; Straub OC
    Berl Munch Tierarztl Wochenschr; 1985 Jul; 98(7):247-50. PubMed ID: 2994624
    [No Abstract]   [Full Text] [Related]  

  • 16. [Testing the activity of anti-foot-and-mouth disease vaccine in cattle: quantitative methods of antigenic extinction].
    Terré J; Stellmann C; Brun A; Favre H; Fontaine J
    Dev Biol Stand; 1976; 35():357-67. PubMed ID: 198306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Waldmann-type and Frenkel-type foot-and-mouth-disease vaccines in pigs.
    Sólyom F; Szent-Iványi M; Deák F
    Acta Vet Acad Sci Hung; 1979; 27(4):391-401. PubMed ID: 232371
    [No Abstract]   [Full Text] [Related]  

  • 18. Experiments on an early protection against foot-and-mouth disease virus.
    Liebermann HT; Thalmann G; Bartels T; Nöckler A
    Acta Virol; 1993; 37(2-3):181-3. PubMed ID: 8105663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effectiveness of foot-and-mouth disease vaccines in Switzerland. I. Screening tests and herd immunity].
    Müller HK; Villinger F; Griot C; Ackermann M; Bruckner L; Kihm U
    Schweiz Arch Tierheilkd; 1989; 131(7):379-86. PubMed ID: 2552579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of laboratory techniques for the evaluation of the antigenic potency of foot-and-mouth disease virus cultures and vaccines.
    Terpstra C; Frenkel S; Straver PJ; Barteling SJ; van Bekkum JG
    Dev Biol Stand; 1976; 35():333-42. PubMed ID: 198304
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.